Dianthus Therapeutics, Inc. DNTH

Full chart Compare
Set alert

Price alert · DNTH

All alert types
82.70 USD +0.45 (+0.55%)

At closeNov 3, 2026, 4:00 PM EST

82.70 0.00 0.00%

After hours · Nov 3, 4:00 PM ET

81.91 Day range 86.17
32.42 52-week range 117.88
YTD
+100.68%
1 year
+143.02%

Revenue & Expenses

Other Income → Expenses: $15.60MExpenses → Selling, General & Admin: $34.33MExpenses → Research & Development: $145.64MGross Profit → Expenses: $2.04MRevenue → Gross Profit: $2.04MNet Loss → Expenses: $162.34MOther Income$15.60MGross Profit$2.04MNet Loss$162.34MExpenses$179.97MSelling, General & Admin$34.33MResearch & Development$145.64MRevenue$2.04M

Latest period ending Dec 31, 2025 · select a line to chart its full history

DNTH annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
2.04M6.24M2.83M6.42M0
2.04M6.24M2.83M6.42M0
-177.93M-101.86M-48.17M-29.70M-74.69M
-162.34M-84.97M-43.55M-28.48M-71.14M
-4.20-2.55-8.45-32.57-20.60
DNTH annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
51.09M22.79M132.32M15.37M133.43M
530.92M374.01M179.41M83.11M189.93M
37.52M21.53M10.54M9.45M17.26M
1.39M1.49M585.00K788.00K0
493.40M352.48M168.87M-44.37M172.67M
DNTH annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-129.06M-78.18M-36.86M-29.07M-59.53M
-122.83M-286.81M20.25M-59.82M43.43M
280.13M255.62M133.57M96.68M89.60M
-213.00K-105.00K-110.00K-139.00K-1.26M
28.23M-109.37M116.97M7.79M73.50M